Development of New Prostate Specific Monoclonal Antibodies

Prostate

Volumn 58, Issue 3, 2004, Pages 225-231

  Lampe, M I ^a   Molkenboer Kuenen, J D M ^a   Oosterwijk, E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Immunohistochemistry; Monoclonal antibody; Prostate cancer

Indexed keywords

MONOCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIBODY; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CONTROLLED STUDY; DRUG TARGETING; FEMALE; HOMOGENATE; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HOMOGENATE; SPLEEN CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CELL LINE, TUMOR; CROSS REACTIONS; FEMALE; HUMANS; HYBRIDOMAS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED BALB C; PROSTATE; PROSTATIC NEOPLASMS;

EID: 0842306318     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10326     Document Type: Article

References (20)

1. Denis LJ, Carnelro de Moura JL, Bono A, Sylvester R, Whelan P, Newling D, Depauw M. Goserelin acetate and flutamide versus bilateral orchiectomy: A phase III EORTC trial (30853). EORTC GU Group and EORTC Data Center. Urology 1993;42:119-129.
2. Kish JA, Bukkapatnam R, Palazzo F. The treatment challenge of hormone-refractory prostate cancer. Cancer Control 2001;8(6):487-495.
3. Oosterwijk E, Ruiter DJ, Hoedemaeker PJ, Pauwels EK, Jonas U, Zwartendijk J, Warnaar SO. Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney. Int J Cancer 1986;38(4):489-494.
4. Fradet Y, Islam N, Boucher L, Parent Vaugeois C, Tardif M. Polymorphic expression of a human superficial bladder tumor antigen defined by mouse monoclonal antibodies. Proc Natl Acad Sci USA 1987;84:7227-7231.
5. Sharon J, Morrison SL, Kabat EA. Detection of specific hybridoma clones by replica immunoadsorption of their secreted antibodies. Proc Natl Acad Sci USA 1979;76:1420-1424.
6. Horig H, Lee CS, Kaufman HL. Prostate-specific antigen vaccines for prostate cancer. Expert Opin Biol Ther 2002;2:395-408.
7. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975;256:495-497.
8. Wang MC, Valenzuela LA, Murphy GP, Chu TM. Purification of a human prostate specific antigen. Invest Urol 1979;17:159-163.
9. Horoszewicz JS, Kawinski E, Murphy GP. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res 1987;7:927-935.
10. Reiter RE, Gu Z, Watabe T, Thomas G, Szigeti K, Davis E, Wahl M, Nisitani S, Yamashiro J, Le Beau MM, Loda M, Witte ON. Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci USA 1998;95:1735-1740.
11. Talwar GP, Gupta R, Gupta SK, Malhotra R, Khanna R, Mitra DK, Sehgal S, Minz R, Kumar A. A monoclonal antibody cytolytic to androgen independent DU145 and PC3 human prostatic carcinoma cells. Prostate 2001;46(3):207-213
12. Beckett ML, Lipford GB, Haley CL, Schellhammer PF, Wright GLJ. Monoclonal antibody PD41 recognizes an antigen restricted to prostate adenocarcinomas. Cancer Res 1991;51:1326-1333.
13. Wright GLJ, Huang CL, Lipford G, Beckett ML, Liang HM, Haley C, Newhall K, Morningstar M. Generation and characterization of monoclonal antibodies to prostate secretory protein. Int J Cancer 1990;46:39-49.
14. Ware JL, Paulson DF, Parks SF, Webb KS. Production of monoclonal antibody alpha Pro3 recognizing a human prostatic carcinoma antigen. Cancer Res 1982;42:1215-1222.
15. Raynor RH, Hazra TA, Moncure CW, Mohanakumar T. Characterization of a monoclonal antibody, KR-P8, that detects a new prostate-specific marker. J Natl Cancer Inst 1984;73:617-625.
16. Carroll AM, Zalutsky M, Schatten S, Bhan A, Perry LL, Sobotka C, Benacerraf B, Greene MI. Monoclonal antibodies to tissue-specific cell surface antigens. I. Characterization of an antibody to a prostate tissue antigen. Clin Immunol Immunopathol 1984;33:268-281.
17. Starling JJ, Sieg SM, Beckett ML, Wirth PR, Wahab Z, Schellhammer PF, Ladaga LE, Poleskic S, Wright GLJ. Human prostate tissue antigens defined by murine monoclonal antibodies. Cancer Res 1986;46:367-374.
18. Chen YT, Scanlan MJ, Sahin U, Tureci O, Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M, Old LJ. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 1997;94:1914-1918.
19. Essand M, Gronvik C, Hartman T, Carlsson J. Radioimmunotherapy of prostatic adenocarcinomas: Effects of 1311-labelled E4 antibodies on cells at different depth in DU 145 spheroids. Int J Cancer 1995;63:387-394.
20. Beckett ML, Wright GLJ. Characterization of a prostate carcinoma mucin-like antigen (PMA). Int Cancer 1995;62:703-710.